Screening for Cognitive Decline in Primary Care
Although an estimated 82 million people worldwide will be affected by dementia by 2030, research demonstrates that cognitive decline often goes unrecognized in primary care settings.
Alzheimer Disease and Dementia
Migraines Linked to Higher Risk for Dementia, Alzheimer Disease
However, no link seen between migraines and vascular dementia.
Essential Steps to Implementing Guidelines for Cognitive Dysfunction in Diabetes
Evidence to date suggests that the risk for all-cause dementia is 40% to 60% higher in patients with type 1 or type 2 diabetes.
Physical Activity and Low Vascular Risk Protective Against Cognitive Decline in AD
Engaging in regular physical activity and taking active measures to reduce vascular risk may have a synergistic effect in delaying the progression of Alzheimer disease.
FDA Warns CBD Product Maker About False Claims
Agency says unproven claims about CBD products could lead consumers to delay medical care.
Family History of Dementia Tied to Early Memory Deficits
Reduced paired-associates learning performance observed long before typical onset of Alzheimer disease.
Cognitive Decline Associated With Successive Amyloid-Beta and Tau Changes
Older adults with an increase in amyloid-β plaques followed by increased tau neurofibrillary tangles have shown lower cognition after 7 years.
Higher LDL-C Levels Linked to Early-Onset Alzheimer Disease
Cases with EOAD have higher levels of LDL-C, greater frequency of rare genetic coding variants of APOB.
Varying Amyloid-β Levels Affect Attitudes Toward Physician-Assisted Death
Attitudes about physician-assisted death vary among patients with Alzheimer disease.
Alzheimer Disease Trials Discontinued Following Disappointing Results With Aducanumab
Alzheimer disease and dementia trials discontinued following disappointing results.
Next post in Neurology Information Center
